Bayer AS - Search Results

1

Bayer AS. Bayer AS. Clin Infect Dis. 1993 Sep;17(3):313-20; quiz 321-2. doi: 10.1093/clinids/17.3.313. Clin Infect Dis. 1993. PMID: 8218670 Review.

2

Staphylococcus aureus bacteremia and endocarditis. New diagnostic and therapeutic concepts.

Mortara LA, Bayer AS. Mortara LA, et al. Among authors: bayer as. Infect Dis Clin North Am. 1993 Mar;7(1):53-68. Infect Dis Clin North Am. 1993. PMID: 8463653 Review.

3

Pulmonic valve endocarditis as an underdiagnosed disease: role of transesophageal echocardiography.

Shapiro SM, Young E, Ginzton LE, Bayer AS. Shapiro SM, et al. Among authors: bayer as. J Am Soc Echocardiogr. 1992 Jan-Feb;5(1):48-51. doi: 10.1016/s0894-7317(14)80102-8. J Am Soc Echocardiogr. 1992. PMID: 1739470

4

Evaluation of new clinical criteria for the diagnosis of infective endocarditis.

Bayer AS, Ward JI, Ginzton LE, Shapiro SM. Bayer AS, et al. Am J Med. 1994 Mar;96(3):211-9. doi: 10.1016/0002-9343(94)90144-9. Am J Med. 1994. PMID: 8154508

5

Transesophageal echocardiography in diagnosis of infective endocarditis.

Shapiro SM, Young E, De Guzman S, Ward J, Chiu CY, Ginzton LE, Bayer AS. Shapiro SM, et al. Among authors: bayer as. Chest. 1994 Feb;105(2):377-82. doi: 10.1378/chest.105.2.377. Chest. 1994. PMID: 8306732

6

Influence of in vitro susceptibility phenotype against thrombin-induced platelet microbicidal protein on treatment and prophylaxis outcomes of experimental Staphylococcus aureus endocarditis.

Dhawan VK, Yeaman MR, Bayer AS. Dhawan VK, et al. Among authors: bayer as. J Infect Dis. 1999 Nov;180(5):1561-8. doi: 10.1086/315063. J Infect Dis. 1999. PMID: 10515816

7

Tricuspid valve endocarditis due to Staphylococcus aureus. Correlation of two-dimensional echocardiography with clinical outcome.

Bayer AS, Blomquist IK, Bello E, Chiu CY, Ward JI, Ginzton LE. Bayer AS, et al. Chest. 1988 Feb;93(2):247-53. doi: 10.1378/chest.93.2.247. Chest. 1988. PMID: 3338291

8

The oxygen- and iron-dependent sigma factor pvdS of Pseudomonas aeruginosa is an important virulence factor in experimental infective endocarditis.

Xiong YQ, Vasil ML, Johnson Z, Ochsner UA, Bayer AS. Xiong YQ, et al. Among authors: bayer as. J Infect Dis. 2000 Mar;181(3):1020-6. doi: 10.1086/315338. J Infect Dis. 2000. PMID: 10720526

9

Comparative pharmacokinetics and pharmacodynamics of amikacin and ceftazidime in tricuspid and aortic vegetations in experimental Pseudomonas endocarditis.

Bayer AS, Crowell DJ, Yih J, Bradley DW, Norman DC. Bayer AS, et al. J Infect Dis. 1988 Aug;158(2):355-9. doi: 10.1093/infdis/158.2.355. J Infect Dis. 1988. PMID: 3042875

10

Predictive risk factors for periannular extension of native valve endocarditis. Clinical and echocardiographic analyses.

Omari B, Shapiro S, Ginzton L, Robertson JM, Ward J, Nelson RJ, Bayer AS. Omari B, et al. Among authors: bayer as. Chest. 1989 Dec;96(6):1273-9. doi: 10.1378/chest.96.6.1273. Chest. 1989. PMID: 2582833

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

395 results

Search Page

Filters